Tafamidis
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB11644 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | primary release disorder of platelets | KG + DL |
| 2 | thrombocytopenic purpura | KG + DL |
| 3 | pseudo-von Willebrand disease | KG + DL |
| 4 | Glanzmann thrombasthenia | KG + DL |
| 5 | primary amyloidosis | KG + DL |
| 6 | acquired amyloid peripheral neuropathy | KG + DL |
| 7 | primary hyperoxaluria | KG + DL |
| 8 | dermis disease | KG + DL |
| 9 | biotin metabolic disease | KG + DL |
| 10 | mixed-type autoimmune hemolytic anemia | KG + DL |
| 11 | drug-induced autoimmune hemolytic anemia | KG + DL |
| 12 | proteinuria | KG + DL |
| 13 | inherited thrombophilia | KG + DL |
| 14 | amyloidosis cutis dyschromia | KG + DL |
| 15 | macular amyloidosis | KG + DL |
| 16 | nodular cutaneous amyloidosis | KG + DL |
| 17 | neonatal autoimmune hemolytic anemia | KG + DL |
| 18 | Ledderhose disease | KG + DL |
| 19 | familial apolipoprotein C-II deficiency | KG + DL |
| 20 | infantile digital fibromatosis | KG + DL |
| 21 | palmar fibromatosis | KG + DL |
| 22 | primary CD59 deficiency | KG + DL |
| 23 | cold agglutinin disease | KG + DL |
| 24 | vitamin deficiency disorder | KG + DL |
| 25 | tinea nigra | KG + DL |
| 26 | Scott syndrome | KG + DL |
| 27 | homozygous familial hypercholesterolemia | KG + DL |
| 28 | immune-mediated necrotizing myopathy | KG + DL |
| 29 | bleeding diathesis due to a collagen receptor defect | KG + DL |
| 30 | antisynthetase syndrome | KG + DL |
| 31 | hemorrhagic disorder due to a constitutional thrombocytopenia | KG + DL |
| 32 | paroxysmal nocturnal hemoglobinuria | KG + DL |
| 33 | idiopathic eosinophilic myositis | KG + DL |
| 34 | inflammatory myopathy with abundant macrophages | KG + DL |
| 35 | focal myositis | KG + DL |
| 36 | hypophosphatasia | KG + DL |
| 37 | reticular dysgenesis | KG + DL |
| 38 | inborn error of biotin metabolism | KG + DL |
| 39 | platelet-type bleeding disorder | KG + DL |
| 40 | Steel syndrome | KG + DL |
| 41 | glaucoma | KG + DL |
| 42 | penile fibromatosis | KG + DL |
| 43 | venous insufficiency (disease) | KG + DL |
| 44 | thrombotic thrombocytopenic purpura | KG + DL |
| 45 | adenosine deaminase deficiency | KG + DL |
| 46 | familial Dupuytren contracture | KG + DL |
| 47 | fetal and neonatal alloimmune thrombocytopenia | KG + DL |
| 48 | severe combined immunodeficiency due to LCK deficiency | KG + DL |
| 49 | acquired hypertrichosis lanuginosa | KG + DL |
| 50 | type II mixed cryoglobulinemia | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.